Your browser doesn't support javascript.
loading
Mathematical modeling and simulation in animal health. Part III: Using nonlinear mixed-effects to characterize and quantify variability in drug pharmacokinetics.
Bon, C; Toutain, P L; Concordet, D; Gehring, R; Martin-Jimenez, T; Smith, J; Pelligand, L; Martinez, M; Whittem, T; Riviere, J E; Mochel, J P.
Afiliação
  • Bon C; Roche Pharmaceutical Research and Early Development, Roche Innovation Center, Basel, Switzerland.
  • Toutain PL; Department of Veterinary Basic Sciences, Royal Veterinary College, Hatfield, UK.
  • Concordet D; Toxalim, Research Centre in Food Toxicology, Toulouse, France.
  • Gehring R; Université de Toulouse, ENVT, INP, Toxalim, Toulouse, France.
  • Martin-Jimenez T; Laboratoire de Physiologie et Thérapeutique, École Nationale Vétérinaire de Toulouse INRA, UMR 1331, Toulouse, France.
  • Smith J; Department of Anatomy and Physiology, College of Veterinary Medicine, Institute of Computational Comparative Medicine (ICCM), Kansas State University, Manhattan, KS, USA.
  • Pelligand L; Department of Comparative Medicine, College of Veterinary Medicine, University of Tennessee, Knoxville, TN, USA.
  • Martinez M; Veterinary Diagnostic and Production Animal Medicine, Iowa State University College of Veterinary Medicine, Ames, IA, USA.
  • Whittem T; Department of Veterinary Basic Sciences, Royal Veterinary College, Hatfield, UK.
  • Riviere JE; Center for Veterinary Medicine, US Food and Drug Administration, Rockville, MD, USA.
  • Mochel JP; Translational Research and Animal Clinical Trials (TRACTs) Group, Faculty of Veterinary and Agricultural Sciences, University of Melbourne, Werribee, Vic., Australia.
J Vet Pharmacol Ther ; 41(2): 171-183, 2018 Apr.
Article em En | MEDLINE | ID: mdl-29226975
ABSTRACT
A common feature of human and veterinary pharmacokinetics is the importance of identifying and quantifying the key determinants of between-patient variability in drug disposition and effects. Some of these attributes are already well known to the field of human pharmacology such as bodyweight, age, or sex, while others are more specific to veterinary medicine, such as species, breed, and social behavior. Identification of these attributes has the potential to allow a better and more tailored use of therapeutic drugs both in companion and food-producing animals. Nonlinear mixed effects (NLME) have been purposely designed to characterize the sources of variability in drug disposition and response. The NLME approach can be used to explore the impact of population-associated variables on the relationship between drug administration, systemic exposure, and the levels of drug residues in tissues. The latter, while different from the method used by the US Food and Drug Administration for setting official withdrawal times (WT) can also be beneficial for estimating WT of approved animal drug products when used in an extralabel manner. Finally, NLME can also prove useful to optimize dosing schedules, or to analyze sparse data collected in situations where intensive blood collection is technically challenging, as in small animal species presenting limited blood volume such as poultry and fish.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Farmacocinética / Dinâmica não Linear / Modelos Teóricos Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Farmacocinética / Dinâmica não Linear / Modelos Teóricos Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2018 Tipo de documento: Article